LOCUS       NP_071405                513 aa                     PRI 24-DEC-2015
DEFINITION  matrix metalloproteinase-27 precursor [Homo sapiens].
ACCESSION   NP_071405
VERSION     NP_071405.2  GI:73808268
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 513)
  AUTHORS   Cominelli A, Gaide Chevronnay HP, Lemoine P, Courtoy PJ, Marbaix E
            and Henriet P.
  TITLE     Matrix metalloproteinase-27 is expressed in CD163+/CD206+ M2
            macrophages in the cycling human endometrium and in superficial
            endometriotic lesions
  JOURNAL   Mol. Hum. Reprod. 20 (8), 767-775 (2014)
   PUBMED   24810263
  REMARK    GeneRIF: MMP-27 is expressed in a subset of endometrial macrophages
            related to menstruation and in ovarian and peritoneal endometriotic
            lesions.
REFERENCE   2  (residues 1 to 513)
  AUTHORS   Cominelli A, Halbout M, N'Kuli F, Lemoine P, Courtoy PJ, Marbaix E,
            Tyteca D and Henriet P.
  TITLE     A unique C-terminal domain allows retention of matrix
            metalloproteinase-27 in the endoplasmic reticulum
  JOURNAL   Traffic 15 (4), 401-417 (2014)
   PUBMED   24548619
  REMARK    GeneRIF: MMP-27 is efficiently retained within the ER due to its
            unique CTE, which does not lead to stable membrane insertion. This
            could represent a novel ER retention system
REFERENCE   3  (residues 1 to 513)
  AUTHORS   Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA,
            Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J,
            Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir
            K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher
            F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ,
            Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker
            J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D,
            Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT,
            Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D,
            Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright
            L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA,
            Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D,
            Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ,
            Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC,
            Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper
            CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M,
            Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM,
            Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL,
            Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen
            SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi
            DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B,
            Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H,
            Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F,
            Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC,
            Vincent D, Bacot F, Tessier DC, Kote-Jarai Z and Easton DF.
  CONSRTM   COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative;
            Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer
            Study Collaborators/British Association of Urological Surgeons'
            Section of Oncology; UK ProtecT (Prostate testing for cancer and
            Treatment) Study Collaborators; PRACTICAL (Prostate Cancer
            Association Group to Investigate Cancer-Associated Alterations in
            the Genome) Consortium
  TITLE     Identification of 23 new prostate cancer susceptibility loci using
            the iCOGS custom genotyping array
  JOURNAL   Nat. Genet. 45 (4), 385-391 (2013)
   PUBMED   23535732
REFERENCE   4  (residues 1 to 513)
  AUTHORS   Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B,
            Yusuf S, Gerstein HC, Engert JC and Anand S.
  CONSRTM   DREAM investigators
  TITLE     Variation at the NFATC2 locus increases the risk of
            thiazolidinedione-induced edema in the Diabetes REduction Assessment
            with ramipril and rosiglitazone Medication (DREAM) study
  JOURNAL   Diabetes Care 33 (10), 2250-2253 (2010)
   PUBMED   20628086
  REMARK    GeneRIF: Observational study of gene-disease association,
            gene-environment interaction, and pharmacogenomic / toxicogenomic.
            (HuGE Navigator)
REFERENCE   5  (residues 1 to 513)
  AUTHORS   Wojciechowski R, Bailey-Wilson JE and Stambolian D.
  TITLE     Association of matrix metalloproteinase gene polymorphisms with
            refractive error in Amish and Ashkenazi families
  JOURNAL   Invest. Ophthalmol. Vis. Sci. 51 (10), 4989-4995 (2010)
   PUBMED   20484597
  REMARK    GeneRIF: Observational study of gene-disease association. (HuGE
            Navigator)
REFERENCE   6  (residues 1 to 513)
  AUTHORS   Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR,
            Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez
            S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M,
            Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C,
            Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, Munroe PB, Day
            IN, Kivimaki M, Whittaker J, Humphries SE and Hingorani AD.
  CONSRTM   ASCOT investigators; NORDIL investigators; BRIGHT Consortium
  TITLE     Gene-centric association signals for lipids and apolipoproteins
            identified via the HumanCVD BeadChip
  JOURNAL   Am. J. Hum. Genet. 85 (5), 628-642 (2009)
   PUBMED   19913121
  REMARK    GeneRIF: Observational study of gene-disease association. (HuGE
            Navigator)
REFERENCE   7  (residues 1 to 513)
  AUTHORS   Nagase H and Woessner JF Jr.
  TITLE     Matrix metalloproteinases
  JOURNAL   J. Biol. Chem. 274 (31), 21491-21494 (1999)
   PUBMED   10419448
  REMARK    Review article
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AY358752.1 and BX102293.1.
            On Aug 26, 2005 this sequence version replaced gi:11545845.
            Summary: Proteins of the matrix metalloproteinase (MMP) family are
            involved in the breakdown of extracellular matrix in normal
            physiological processes, such as embryonic development,
            reproduction, and tissue remodeling, as well as in disease
            processes, such as arthritis and metastasis. Most MMP's are
            secreted as inactive proproteins which are activated when cleaved
            by extracellular proteinases. [provided by RefSeq, Jul 2008].
            ##Evidence-Data-START##
            Transcript exon combination :: AY358752.1, AF195192.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
            SAMEA2147596, SAMEA2162823
            [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..513
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="11"
                     /map="11q24"
     Protein         1..513
                     /note="matrix metalloproteinase 27; matrix metalloprotease
                     27; matrix metalloproteinase-27"
                     /product="matrix metalloproteinase-27 precursor"
                     /calculated_mol_wt="56997"
     sig_peptide     1..17
                     /calculated_mol_wt="2048"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     Region          26..86
                     /note="Putative peptidoglycan binding domain; pfam01471"
                     /db_xref="CDD:250643"
                     /region_name="PG_binding_1"
     Region          89..96
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Cysteine switch. {ECO:0000250}"
     Region          106..261
                     /note="Matrixin; pfam00413"
                     /db_xref="CDD:249842"
                     /region_name="Peptidase_M10"
     Region          106..261
                     /note="Zinc-dependent metalloprotease, matrix
                     metalloproteinase (MMP) sub-family. MMPs are responsible
                     for a great deal of pericellular proteolysis of
                     extracellular matrix and cell surface molecules, playing
                     crucial roles in morphogenesis, cell fate...; cd04278"
                     /db_xref="CDD:239805"
                     /region_name="ZnMc_MMP"
     Site            order(157,170,177..183,192,216..217,226,236..238)
                     /note="TIMP-binding surface"
                     /db_xref="CDD:239805"
                     /site_type="other"
     Site            order(216..217,220,226)
                     /db_xref="CDD:239805"
                     /site_type="active"
     Region          276..465
                     /note="Hemopexin-like repeats.; Hemopexin is a heme-binding
                     protein that transports heme to the liver. Hemopexin-like
                     repeats occur in vitronectin and some matrix
                     metalloproteinases family (matrixins). The HX repeats of
                     some matrixins bind tissue inhibitor of...; cd00094"
                     /db_xref="CDD:238046"
                     /region_name="HX"
     Region          276..325
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Hemopexin 1"
     Site            order(286,288,330,332,377,379,426,428)
                     /note="Metal binding sites [ion binding]"
                     /db_xref="CDD:238046"
                     /site_type="metal-binding"
     Region          326..371
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Hemopexin 2"
     Region          373..421
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Hemopexin 3"
     Region          422..465
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Hemopexin 4"
     Region          466..513
                     /note="propagated from UniProtKB/Swiss-Prot (Q9H306.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="Required for retention in the endoplasmic
                     reticulum. {ECO:0000269|PubMed:24548619}"
     CDS             1..513
                     /coded_by="NM_022122.2:24..1565"
                     /gene="MMP27"
                     /gene_synonym="MMP-27"
                     /db_xref="CCDS:CCDS8319.1"
                     /db_xref="GeneID:64066"
                     /db_xref="HGNC:HGNC:14250"
ORIGIN
        1 mkrllllflf fitfssafpl vrmteneenm qlaqaylnqf ysleiegnhl vqsknrslid
       61 dkiremqaff gltvtgklds ntleimktpr cgvpdvgqyg ytlpgwrkyn ltyriinytp
      121 dmaraavdea iqeglevwsk vtplkftkis kgiadimiaf rtrvhgrcpr yfdgplgvlg
      181 hafppgpglg gdthfdeden wtkdgagfnl flvaahefgh alglshsndq talmfpnyvs
      241 ldprkyplsq ddingiqsiy gglpkepakp keptiphacd pdltfdaitt frrevmffkg
      301 rhlwriyydi tdvefelias fwpslpadlq aayenprdki lvfkdenfwm irgyavlpdy
      361 pksihtlgfp grvkkidaav cdkttrktyf fvgiwcwrfd emtqtmdkgf pqrvvkhfpg
      421 isirvdaafq ykgffffsrg skqfeydikt knitrimrtn twfqckepkn ssfgfdinke
      481 kahsggikil yhkslslfif givhllknts iyq
//
